Search

Your search keyword '"Dunning A.M."' showing total 313 results

Search Constraints

Start Over You searched for: Author "Dunning A.M." Remove constraint Author: "Dunning A.M."
313 results on '"Dunning A.M."'

Search Results

2. GENETICALLY-BASED COX-NTCP MODELS FOR LATE TOXICITY AFTER PROSTATE CANCER RT

3. MO-0056 NTCP Models for Late Tissue Fibrosis Following Breast RT are Validated in a Large Prospective Cohort

6. Genome wide association study of long-term patient-reported outcomes following radiotherapy for breast cancer – results from the REQUITE cohort study

8. Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women

9. Breast cancer risks associated with missense variants in breast cancer susceptibility genes

10. Cross-Cancer Genome-Wide Association Study of Endometrial Cancer and Epithelial Ovarian Cancer Identifies Genetic Risk Regions Associated with Risk of Both Cancers.

11. MO-0557 Estimates of α/β ratios for individual late urinary toxicity endpoints: analysis of a cohort trial

12. MO-0801 Machine learning based models of radiotherapy-induced skin induration for breast cancer patients

13. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element

14. Multi-stage genome-wide association study identifies new susceptibility locus for testicular germ cell tumour on chromosome 3q25

16. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

17. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

18. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature Communications, (2021), 12, 1, (1078), 10.1038/s41467-020-20496-3).

19. Breast cancer risk factors and survival by tumor subtype: Pooled analyses from the breast cancer association consortium.

20. Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction (Nature Genetics, (2021), 53, 1, (65-75), 10.1038/s41588-020-00748-0).

21. Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer.

22. Mendelian randomisation study of smoking exposure in relation to breast cancer risk.

23. Genetic insights into biological mechanisms governing human ovarian ageing.

24. Breast cancer risk genes - Association analysis in more than 113,000 women.

25. Erratum: Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature communications (2021) 12 1 (1078)).

26. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element.

27. CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers.

28. Combined Associations of a Polygenic Risk Score and Classical Risk Factors with Breast Cancer Risk.

29. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

30. First international workshop of the ATM and cancer risk group (4-5 December 2019).

31. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.

32. Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.

33. Gene-environment interactions relevant to estrogen and risk of breast cancer: Can gene-environment interactions be detected only among candidate snps from genome-wide association studies?.

34. Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.

35. Common variants in mismatch repair genes and risk of colorectal cancer

36. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk

37. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

38. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

39. Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility

40. Two truncating variants in FANCC and breast cancer risk.

41. Prediction of contralateral breast cancer: external validation of risk calculators in 20 international cohorts.

42. Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.

43. Prediction and clinical utility of a contralateral breast cancer risk model.

44. Cancer risks associated with germline PALB2 pathogenic variants: An international study of 524 families.

45. A network analysis to identify mediators of germline-driven differences in breast cancer prognosis.

46. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.

47. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status.

48. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.

49. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk

50. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

Catalog

Books, media, physical & digital resources